ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
60,666.69
-0.24%
S&P 500
5,477.90
0.16%
Dow Jones
39,127.80
0.04%
US Dollar vs Yen
160.4335
-0.12%
Brent Oil
84.335
-0.16%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Emmaus Life Sciences Inc (EMMA)

  7. Emmaus Life Sciences Inc (EMMA) ニュース

EMMA

Emmaus Life Sciences (EMMA)

Emmaus Life Sciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:EMMA
日付受信時刻ニュースソース見出しコード企業名
2023/05/1600 : 40AllPennyStocks.comBiopharma Reports Fifth Quarter of Increased Net RevenuesNASDAQ:EMMAEmmaus Life Sciences Inc
2022/06/2421 : 35GlobeNewswire Inc.Life Sciences Investor Forum Presentations Now Available for On-Demand ViewingNASDAQ:EMMAEmmaus Life Sciences Inc
2020/03/3022 : 16GlobeNewswire Inc.Life Sciences Companies Investors Presentations Now Available for On-Demand ViewingNASDAQ:EMMAEmmaus Life Sciences Inc
2020/03/2421 : 30GlobeNewswire Inc.Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020NASDAQ:EMMAEmmaus Life Sciences Inc
2020/03/2321 : 35GlobeNewswire Inc.Emmaus Life Sciences to Webcast Live at Life Sciences Investor Forum March 26thNASDAQ:EMMAEmmaus Life Sciences Inc
2020/01/0706 : 11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EMMAEmmaus Life Sciences Inc
2019/12/2403 : 43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EMMAEmmaus Life Sciences Inc
2019/12/0304 : 11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:EMMAEmmaus Life Sciences Inc
2019/11/1407 : 07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EMMAEmmaus Life Sciences Inc
2019/09/1021 : 00PR Newswire (US)Emmaus Life Sciences to be Delisted from Nasdaq Stock Market Following HearingNASDAQ:EMMAEmmaus Life Sciences Inc
2019/09/0321 : 30PR Newswire (US)Emmaus Life Sciences Granted European Patent for use of Pharmaceutical-grade L-glutamine in Treating DiverticulosisNASDAQ:EMMAEmmaus Life Sciences Inc
2019/08/2903 : 16PR Newswire (US)Emmaus Life Sciences Adds Oncology Supply as DistributorNASDAQ:EMMAEmmaus Life Sciences Inc
2019/08/1420 : 00PR Newswire (US)Emmaus Life Sciences to Host "Sideline Sickle Cell" Community Town Hall with ASAP and FSCDR in South FloridaNASDAQ:EMMAEmmaus Life Sciences Inc
2019/08/1221 : 00PR Newswire (US)Emmaus Life Sciences Reports Sharply Improved 2019 Second Quarter Financial ResultsNASDAQ:EMMAEmmaus Life Sciences Inc
2019/08/0904 : 51PR Newswire (US)Emmaus Life Sciences Reiterates Financial Benefits from Recent MergerNASDAQ:EMMAEmmaus Life Sciences Inc
2019/07/2921 : 00PR Newswire (US)Emmaus Life Sciences Details Financial Benefits from Recent Merger, including Improved Balance Sheet and Reduced Debt ServiceNASDAQ:EMMAEmmaus Life Sciences Inc
2019/07/1823 : 42GlobeNewswire Inc.Telemynd Provides Update Following Spinoff Transaction from Emmaus Life Sciences, Formerly MYnd AnalyticsNASDAQ:EMMAEmmaus Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:EMMA

最近閲覧した銘柄

AMEX
SPY
SPDR S&P 500
AMEX
XLF
Financial Select Sector
NYSE
CVX
Chevron
NASDAQ
AMZN
Amazon.com
NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
FX
USDGBP
US Dollar vs Sterling
NASDAQ
NVDA
NVIDIA
COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
PM
XAUUSD
Gold vs US Dollar
SPI
SP500
S&P 500
USOTC
BASFY
BASF (QX)
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有